Transplant Diagnostics Market by Product & Services (Reagents & Consumables, Software & Services, Instruments), Technology (Molecular Assay Technology, Non-Molecular Assay Technology), Application (Diagnostic Applications, Research Applications), Transplant Type (Stem Cell Transplantation, Soft Tissue Transplantation and, Solid Organ Transplantation), End User (Research Laboratories & Academic Institutions, Hospitals & Transplant Centers) - Analysis & Forecast 2019-2030
Report ID : 98 | Published Date : May 2019 | Pages : 150 | Region : Global | Report Code : BT-18
Transplant Diagnostics Market Overview and Introduction
The Global Transplant Diagnostics Market is estimated to be over US$ 3.40 Billion in 2018. It is anticipated to grow At a Double Digit CAGR from 2019 to 2030.
Transplantation is defined as the surgical procedure of transferring damaged cells, tissues or organs called a graft, from one individual and placing them into a same or different individual. Diagnostics tests in transplantations play an important role in checking, rejection monitoring and Human Leukocyte Antigen (HLA). The transplantation diagnostics tests aid in the detection of HLA compatibility between the donor and recipient before transplantation procedures. These tests are used to monitor transplanted organs post-surgery for rejection. On the basis of source of transplant organ, transplant diagnostics are categorized into autografts, allografts and xenografts.
The global transplantation diagnostics market is driven by increase in geriatric population, rising applications of HLA typing products in clinical diagnostics, increasing awareness regarding organ transplantation, improving healthcare infrastructure, rising prevalence of chronic diseases and technological advancements. Moreover, continuous decrease in the average cost of gene sequencing, rising number of soft tissue transplantations and increasing installed base of PCR and NGS instruments is supporting the growth of this market. However, the high cost of transplantation procedures coupled with limited reimbursement of transplantation procedures is likely to restrain the market.
Transplant Diagnostics Market by Product & Services
On the basis of product and services, the market is segmented into reagents & consumables, software & services and instruments. The reagents & consumables segment is expected to account for the largest share of this market owing to factors such as rising number of organ transplantation procedures, growing adoption of transplantation techniques.
Transplant Diagnostics Market by Technology
Based on technology, the market is divided into molecular assay technologies and non-molecular assay technologies. Molecular assay technologies are further divided into PCR-based molecular assay technologies and sequencing based molecular assay technologies. PCR-based molecular assay technologies are subcategorized into real-time PCR, sequence-specific oligonucleotide-PCR, sequence specific primer and other PCR technologies. Sequencing-based molecular assay technologies are subdivided into Sanger sequencing, next generation sequencing and other sequencing technologies. The molecular assay technology segment is anticipated to hold the largest share of this market due to increasing capital for the development of advanced transplant diagnostics products.
Transplant Diagnostics Market by Application
On the basis of application, the market is classified into diagnostic applications and research applications. The diagnostic applications segment is further classified into pre-transplantation applications and post-transplantation applications. The diagnostics applications segment is expected to dominate the market owing to the factors such as rising prevalence of chronic diseases and major risk of genetic diseases after transplantation.
Transplant Diagnostics Market by Transplant Type
Based on transplant type, the market is segmented into stem cell transplantation, soft tissue transplantation and solid organ transplantation. The government initiatives to support organ donation, increasing number of chronic disorders are the factors supporting the growth of the market.
Transplant Diagnostics Market by End Users
On the basis of end user, the market is categorized into research laboratories & academic institutions and hospitals & transplant centers.
Transplant Diagnostics Market by Region
The global market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of transplant diagnostics, followed by Europe and Asia Pacific. North America will continue to dominate the global market in the forecast period owing to factors such as higher healthcare expenses, large demand for the advanced techniques and diagnostics tools and increase in geriatric population. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered in China, India. Factors such as major pool of patients, improving healthcare infrastructure and investment in stem cells are likely to attract patients from different parts of the world.
Transplant Diagnostics Market Prominent Players
The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, IVD Holdings, Inc., Gendx, Luminex Corporation and, Omixon Inc. among others.